Influenza vaccination among cardiovascular disease sufferers in Spain: related factors and trend, 1993-2003

Vaccine
Rodrigo Jiménez-GarcíaAngel Gil de Miguel

Abstract

Based on data drawn from the 1993 and 2003 National Health Surveys (NHS), we sought to: estimate influenza vaccination coverages among Spanish cardiovascular disease (CVD) sufferers; study which variables were associated with the likelihood of being vaccinated; analyze the time-trend in coverage for the period 1993-2003. For study purposes, a CVD sufferer was defined as any adult who reported suffering from high blood pressure and/or heart disease. The proportion of vaccinated adult CVD sufferers in 1993 and 2003 totalled 39.96% and 51.73%, respectively. The following variables increased the likelihood of being vaccinated: higher age; male gender; presence of respiratory chronic diseases; non-smoker status. Coverages for CVD sufferers had improved significantly from 1993 to 2003 but still remain below desirable levels. The improvement over time is mainly due to the subgroup aged >64 years. Strategies must be implemented to improve the use of influenza vaccine among CVD sufferers in Spain in general, and among the younger age-groups in particular.

References

Feb 26, 1997·JAMA : the Journal of the American Medical Association·C W LeBaronR Bernier
Nov 5, 1999·Preventive Medicine·G B Chapman, E J Coups
Apr 4, 2003·The New England Journal of Medicine·Kristin L NicholMarika Iwane
Jul 3, 2003·Journal of the American Pharmacists Association : JAPhA·Khalid M KamalMayur M Amonkar
Jan 20, 2004·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·David G Meyers
Nov 4, 2004·JAMA : the Journal of the American Medical Association·A C G VoordouwBruno H Ch Stricker
Feb 16, 2005·Expert Opinion on Biological Therapy·Mohammad MadjidWard Casscells
Apr 22, 2005·Vaccine·Rodrigo Jiménez-GarcíaAngel Gil de Miguel
Jun 11, 2005·Stroke; a Journal of Cerebral Circulation·Armin J GrauFlorian Buggle
Jul 15, 2005·Annals of the New York Academy of Sciences·Victor S GurevichMargarita V Levaya
Jul 26, 2005·Vaccine·UNKNOWN Macroepidemiology of Influenza Vaccination (MIV) Study Group
Jul 27, 2005·Diabetes Care·Rodrigo Jiménez-GarcíaAngel Gil de Miguel
Sep 15, 2005·Archives of Internal Medicine·Peng-Jun LuCarolyn Buxton Bridges

❮ Previous
Next ❯

Citations

Nov 11, 2008·European Heart Journal·Cinta de DiegoUNKNOWN EPIVAC Study Group
Jul 28, 2010·Vaccine·Rodrigo Jiménez-GarcíaPilar Carrasco-Garrido
Jun 9, 2009·Medicina clínica·María Auxiliadora Martín MartínezAntonio Sarría Santamera
May 12, 2009·Respiratory Medicine·Rodrigo Jiménez-GarcíaAngel Gil de Miguel
May 4, 2016·European Journal of Internal Medicine·Pamela BarbadoroEmilia Prospero
Jul 29, 2021·Journal of the American Heart Association·Priyanka BhugraKhurram Nasir

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.